Artomey; Valopride; Bromoprida; Viaben; VAL 13081; 4-Amino-5-bromo-N-(2-(diethylamino)ethyl)-o-anisamide; UNII-75473V2YZK; 4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide; Emepride; 75473V2YZK; NCGC00016646-02; Benzamide, 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxy-; DSSTox_CID_25383; DSSTox_RID_80841; DSSTox_GSID_45383; Bromoprida [Spanish]; C14H22BrN3O2; o-Anisamide, 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-; Bromopridum; Emoril; Viadil; Bromopride [INN:DCF]; o-ANISAMIDE, 4-AMINO-5-BROMO-N-(2-(DIETHYLAMINO)ETHYL)-; Bromopridum [INN-Latin]; Bromoprida [INN-Spanish]; SR-01000841242; EINECS 223-842-2; BRN 2381893; Bromoprid; 4-amino-5-bromo-N-(2-(diethylamino)ethyl)-2-methoxybenzamide; Movipride (TN); Prestwick_61; Bromopride (INN); N-(Diethylaminoethyl)-2-methoxy-4-amino-5-bromobenzamide; Spectrum_001394; Prestwick0_000704; Prestwick1_000704; Prestwick2_000704; Prestwick3_000704; Spectrum2_001527; Spectrum3_001559; Spectrum4_000726; Spectrum5_000970; SCHEMBL54497; BSPBio_000887; BSPBio_003038; KBioGR_000992; KBioSS_001874; MLS002153965; DivK1c_000317; SPECTRUM1503108; SPBio_001314; SPBio_002808; BPBio1_000977; CHEMBL399510; DTXSID0045383; HMS500P19; KBio1_000317; KBio2_001874; KBio2_004442; KBio2_007010; KBio3_002538; NINDS_000317; HMS1570M09; HMS1922E21; HMS2097M09; HMS2230K23; HMS3374M06; HMS3714M09; Pharmakon1600-01503108; HY-B1164; ZINC2038104; Tox21_110543; BDBM50247887; CCG-39305; NSC758391; AKOS015994598; Tox21_110543_1; CS-4764; DB09018; HS-0004; NSC-758391; IDI1_000317; NCGC00016646-01; NCGC00016646-05; NCGC00095309-01; SMR001233304; SBI-0051774.P002; AB00052316; FT-0663848; D07101; AB00052316_08; Q1958189; SR-01000841242-2; SR-01000841242-3; BRD-K73642618-001-05-9; BRD-K73642618-001-08-3; 4-Amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide #; Benzamide, 4-amino-5-bromo-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)